Stockreport

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF ? Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million ? ? Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ? ? FY [Read more]